Publications & News Archives

5 of the Biggest Licensing Deals of 2024 So Far

The life sciences industry thrives on innovation, and licensing deals play a crucial role in driving that progress. For companies in biotech, pharmaceuticals and medtech, staying informed on the biggest licensing deals gives strategic insights that could shape their own growth. By leveraging resources like the Biotechgate database, which houses over 30,000 licensing agreements, companies […]

25 Oct 2024

The Elements of Structuring a Licensing Deal

Negotiating a licensing deal can be a difficult undertaking, with a variety of challenges to overcome and options to include, such as whether to opt for an exclusive or non-exclusive agreement and what payment structure to choose. Here, we will discuss some options to consider when setting up your next deal. Geographical Scope Defining the […]

23 Oct 2024

The Value of a Strong Online Presence in the Biotech and Pharma Industry

Establishing a strong online presence has never been so important for Biotech and Pharma companies as it allows them to showcase their innovations, improve networking opportunities, reach potential partners, and drive growth in a highly competitive market. There are some key areas companies should pay attention to, to help create and grow a strong online […]

23 Sep 2024

How to Effectively Use LinkedIn as a Life Sciences Company

LinkedIn is a vital tool for the life sciences industry. The platform allows companies to build their brand, connect with key stakeholders and grow their business through targeted networking. In an industry where credibility and industry connections are paramount, effectively using LinkedIn can help foster industry partnerships, attract top talent and establish your organization as […]

21 Sep 2024

Increase Your Company Visibility with Biotechgate

Biotechgate is a global database with over 60,000 life science companies listed, increasing their visibility to potential partners and investors. Being listed is free of charge and you can update your company profile whenever you wish. Read the following step-by-step guide to learn how to request a listing of your company if it is missing […]

20 Sep 2024

Why Data is Important for Pharmas and Biotechs

Data is a commodity across all life science companies, serving to help drive an organization’s strategic direction and helping to understand what has and has not worked in the past. With the increased emphasis being focused on the variety of uses of data in day-to-day business operations, here are some reasons why it can be […]

23 Aug 2024

The Role of Artificial Intelligence in the Biopharma Industry

Artificial intelligence (AI) has found itself being utilized with increased frequency within the biopharma industry, with companies often collaborating with AI platform providers for a myriad of reasons and mutual benefits. In this article, find out about the growing role that AI is currently playing within a sector that is constantly evolving. Searching for Drug […]

23 Aug 2024

How Biotechgate Creates a Global Database

With over 1.4 million total entries in the database, we have different tools as well as a team of analysts in place to ensure that Biotechgate users have the most accurate and up-to-date information possible. We utilize a unique data sourcing process to gather a large amount of life science information on both large multinationals […]

22 Aug 2024

Why You Should Use Analyst Research Reports

The life science industry is characterized by intense competition, requiring biotech and pharma companies to build a comprehensive understanding of their market. Analyst market research reports by top brokerage houses, offer a wealth of information, from market trends to competitive analysis, providing a solid foundation for strategic planning and innovation. In this article, we explore […]

24 Jul 2024

Using Competitive Intelligence in Biotech & Pharma

Staying up-to-date on who your competitors are and their recent developments should be a crucial aspect of your business strategy to maintain a competitive advantage and avoid losing market share. Whether you are part of an established company or a new entrant in the industry, understanding the competitive landscape is essential. However, knowing which aspects […]

21 Jul 2024

Identifying Competitors with Biotechgate

Whether you are working with an established organization or a new start-up, having an in-depth knowledge of your competitors’ offerings, business model, and where they add value is crucial to facilitating the longevity of your organization. Who your competitors are is dependent on your overall business strategy and current situation. You may choose to focus […]

17 Jul 2024

Clinical Trials Overview 2024: Key Insights from Biotechgate

As the cornerstone of the biopharma industry, the clinical trials market is projected to reach a value of over USD 153 billion by 2033, according to Nova One Advisor. The Biotechgate clinical trials section, launched in 2019, currently lists over 920,000 studies and is continuously updated with new information for trials, covering both well-known areas […]

18 Jun 2024

How to Successfully Manage Early-Stage Clinical Trials

The overall success rate of clinical trials is only 7.9%, highlighting the significant risks for biopharmaceutical companies when bringing a drug to market. Early-stage clinical trials determine the future development of a new drug and effective management at this stage is crucial for the success of new treatments and therapies. In this article, read about […]

18 Jun 2024

Top mRNA Vaccines in Development

Having seen its popularity explode thanks to its utilization against COVID-19 in 2020, messenger RNA (mRNA) vaccines have been an increasing source of diversification for companies in the biopharma industry, including advantages over traditional drugs such as being easily programmable, while also reducing development risk and financial costs. This has led to the sector exploring […]

18 Jun 2024

Introducing the New Version of Biotechgate

We are pleased to announce the upcoming launch of a new version of the Biotechgate database, scheduled for the end of May. The release features an enhanced user experience and several new functionalities, including a new M&A section and access to analyst reports and forecasts. In this article, be introduced to the potential of the […]

23 May 2024

How the Life Sciences Industry Integrates Industry 4.0 Concepts

Industry 4.0 is a concept that represents the integration of advanced digital technologies into manufacturing and production processes. Leveraging technologies such as the Internet of Things (IoT) and artificial intelligence (AI) within the life sciences industry enhances drug discovery, patient communication, and more. In this article, we explore three key trends surrounding Industry 4.0, and […]

22 Apr 2024

5 Digital Therapeutics Companies To Watch

Digital therapeutics (DTx) is a rapidly evolving field that seeks to revolutionize healthcare delivery. Considered a subset of digital health, DTx is defined as evidence-based therapeutic interventions driven by software to prevent, manage, or treat a medical disorder or disease. In this article, we’ll explore five companies pioneering innovations in the DTx space. Biofourmis View […]

22 Apr 2024

Leveraging Incubators & Accelerators as a Start-Up

Incubators and accelerators play a pivotal role in fostering start-ups and enabling them to research and ultimately commercialize their products, as well as offering numerous other services. In this article, find out how a biotech start-up can benefit from joining an incubator or accelerator. Some key differences separate incubators from accelerators. One of the most […]

20 Mar 2024

Financing in Medtech: An Overview

In recent years, the medical technology (medtech) industry has attracted significant attention from investors and companies alike, driven by ongoing innovation. In this article, utilizing the data Biotechgate has to offer on the medtech field, you’ll find an overview of how funding in the industry has developed, including a review of the past and what’s […]

16 Feb 2024

Medtech Categorization in Biotechgate Explained

The Medical Technology (medtech) category is one of the six core company sectors in the Biotechgate database. Read our brief overview on what exactly this area consists of and how we define companies that fall under the medtech umbrella. Based on our categorization system, medtech companies are defined as those involved in the research, development, […]

16 Feb 2024

5 Medtech Start-Ups to Watch in 2024

Given that the majority of startups in the medtech industry fail in the long run, with 60% of startups not surviving the first five years according to recent studies, it is particularly interesting to keep an eye on the successful start-ups that have performed well in the recent past. Here is a list of five […]

16 Feb 2024

Top 10 Largest Financing Rounds in 2023

In what could be termed as a cautious year, there was still plenty of financing round activity in the life sciences industry. Based on Biotechgate data, these are the top 10 rounds sorted by the amount raised. Notably, private equity rounds have not made the cut for the list. 10. Vaxcyte View on Biotechgate » […]

25 Jan 2024

The 5 Largest Life Science M&A Deals of 2023

Despite uncertainties continuing from 2022 into 2023, the year saw a wide range of deals take place spanning across the industry. This article will highlight the top 5 deals that were completed throughout 2023. 5. Biogen and Reata Pharmaceuticals Deal value: USD 7.3 billion Date completed: July 2023 Biogen emerged victorious in a bidding war […]

25 Jan 2024

How AI is Transforming Healthcare

Artificial Intelligence has emerged as an integral force in the global digital health industry, transforming the way healthcare data is analyzed and diseases are diagnosed. AI and machine learning hold the promise of delivering more personalized and accessible healthcare. In this article, we will have a deeper look into some of the innovations AI technology […]

17 Nov 2023

6 AI-Driven Companies to Watch

Artificial intelligence (AI) is being rapidly integrated by life science companies seeking to reduce costs, become more efficient and enhance their automation, with this process only being spurred on by the COVID-19 pandemic. In this article, we’ve put together a list of companies to keep an eye on, with their operations centered on AI. 1. […]

17 Nov 2023

How Biotechgate Uses Artificial Intelligence

At Biotechgate, we provide you with a comprehensive life sciences database, allowing users access to up-to-date information covering companies, licensing deals, financing rounds and more. We use a unique data-sourcing process to gather large amounts of information across the entire biopharma industry, giving Biotechgate users access to unprecedented information – thanks, in part, to artificial […]

17 Nov 2023

The Current State of M&A Activity in the Life Sciences Industry

The life sciences industry is no stranger to mergers and acquisitions (M&As), helping to expand product portfolios, access new markets and pursue new innovations, amongst a myriad of other reasons. In this article, we will look at the current state of M&A activity based on data from the Biotechgate database, with insights on where the […]

20 Oct 2023

Life Sciences M&A Report: Half-Year 2023

In the first half of 2023, the slowdown in terms of global life sciences M&A deal-making experienced in the second half of 2022 has continued to show its effects. Anticipated as a year of recovery, 2023 was expected to leverage M&A as a means to adapt to rapidly changing market conditions. However, while it remains […]

20 Oct 2023

Interoperability in Digital Health: Driving Innovation for Better Patient Care

Data interoperability in the digital health industry is more than just a buzzword: It stands for the potential to transform the way healthcare providers exchange electronic patient data. In this article, we will explore the importance of interoperability and the challenges it faces. Find out how to discover companies in Biotechgate that lead the development […]

22 Sep 2023

Financing in Digital Health: An Overview

Digital health is an industry in the life sciences experiencing constant innovation as well as attention from both investors and fellow companies. The Biotechgate Business Development Database contains an array of up-to-date information on digital health. In this article, you’ll find an overview of how funding in the industry has developed and further analysis of […]

22 Sep 2023

The Top 5 Biggest Licensing Deals of 2023 So Far

As biotechs face a challenging commercial environment with limited options for IPOs, interest in forging partnership agreements remains high. This article explores five top biotech and pharma licensing deals, ranked by the potential total deal value, that 2023 has brought to date. From advancing precision oncology to regenerative medicine, these partnerships underscore a commitment to […]

24 Aug 2023

Biotech Product Valuation: Setting a Price for Acquisitions

Navigating the complex landscape of biotech valuations is often more of an art than a science. This article shows the methodologies and considerations implemented when assessing biotech products in a field where industry meets commerce. Big acquisitions like the purchase earlier in 2023 by Merck of Prometheus Biosciences are very good examples of how valuation […]

24 Aug 2023

Venture Valuation/Biotechgate and AdvaMed Form Strategic Partnership to Drive MedTech Industry Growth

Media Release Zurich, Switzerland and Washington, D.C., USA, August 2023 – Biotechgate, a global business development and licensing database for the life sciences industry, is proud to announce its strategic partnership with the Advanced Medical Technology Association (AdvaMed). This collaboration aims to strengthen the data integration in Biotechgate, while enhancing the visibility and insight into […]

10 Aug 2023

The Impact of University Spin-offs in the Life Sciences

University spin-offs have emerged as powerful drivers of innovation and commercialization in the life sciences industry. These companies, born out of academic research, have paved the way for groundbreaking technologies and advancements that have shaped the biopharma industry. In this article, we’ll explore the impact that university spin-offs are having in the life sciences. Prominent […]

21 Jun 2023

Exploring Life Science Spin-offs

The foundation of companies is a dynamic process in the life science landscape. Academic spin-offs, where research is transformed into market opportunities, as well as spin-offs from other public institutions or established companies within the industry are common pathways. For business development professionals, understanding the circumstances in which companies are founded provide valuable context: It […]

21 Jun 2023

Breaking Down the Latest Trends in Clinical Trials: Insights from Biotechgate

Serving as the backbone of the biopharma industry, the clinical trials market is expected to reach a value of USD 84.43 billion by 2030 according to Precedence Research. The Biotechgate database lists over 780,000 trials and is continuously updated with new information for trials covering both well-known areas like oncology as well as orphan diseases […]

17 May 2023

Transforming Clinical Trials Through Technology: A Look into Key Trends

In the world of clinical trials, technology is transforming the way pharmaceutical companies conduct research and develop life-saving therapies. In response to the pandemic, where traditional methods of conducting clinical trials faced challenges due to restrictions on physical contact, the industry has seen a 50% increase in trials involving digital technologies such as wearables from […]

17 May 2023

How to Find the Latest Clinical Trials

If you’re a business development professional searching for early-stage companies and assets, Biotechgate’s clinical trial directory is an invaluable resource. With over 780,000 clinical studies gathered from various trial registries worldwide, it can be overwhelming to find the latest clinical trials. This guide will show you how easy it can be. Once you are logged […]

16 May 2023

5 Ways to Make the Most of Your Next Partnering Conference

Partnering conferences are a valuable opportunity for life sciences companies to network and find potential partners or investors. These events bring together key players from around the world to discuss the latest trends and innovations in the field. But preparing for a conference can be overwhelming, and it’s easy to get lost in the chaos […]

20 Apr 2023

Factors to Consider When Choosing a Life Science Partner

Selecting the right life science partner is a critical decision for any biotech company. A successful partnership can help drive research and development efforts and lead to the successful commercialization of products. Crossing both the scientific and business side, here are some important factors to consider when choosing your next life science partner. Intellectual Property […]

19 Apr 2023

Life Sciences M&A Report 2022

In line with the broader negative trend in overall M&A investment worldwide, the global M&A activity in the life sciences industry experienced a slowdown in 2022: M&A activity declined significantly in both the number and value of deals compared to the previous year. However, there is hope that 2023 will be a more active year […]

27 Mar 2023

The World’s Biotech Hotspots

Biotechnology is an industry that has always been centered around a culture of innovation and collaboration on a global scale. In this article, you’ll find an overview of some of the key hotspots in the biotech industry. International collaborations are a constantly recurring theme in the life sciences. 6 of the 10 largest deals in […]

21 Mar 2023

Biotechgate: Your Gateway to the International Life Sciences Industry

As a global business development database, Biotechgate can aid you in accessing the international life science industry in many ways. The database offers various features and filter options designed to facilitate access to information on companies in a wide variety of countries and regions. What’s more, Biotechgate partners with industry organizations from all over the […]

21 Mar 2023

Biotechgate Partners with ALLIS-NA: Launch of Member Directory

Media Release Launch of Member Directory for ALLIS-NA Zurich, Switzerland and Bordeaux, France, March 2023 – Venture Valuation/Biotechgate is proud to announce its partnership with the French regional health cluster Alliance Innovation Santé Nouvelle-Aquitaine (ALLIS-NA). The two organizations are collaborating to accelerate both the data integration in Biotechgate and economic development of the life science […]

15 Mar 2023

Exploring Non-Dilutive Financing Options for Life Science Companies

Bringing innovative ideas and technologies to market in the highly competitive life science industry is a challenging task for companies. To raise the investment needed to achieve this goal, venture capital is a popular option, but it is often a time-consuming process and hard to secure. Particularly early-stage companies looking to reduce pressure and maintain […]

24 Feb 2023

The Current State of Debt Financing for Biotechs

Biotech companies are always on the lookout for additional cash given the R&D-focused spend of the industry. Amid a downtrend in the market, private equity and IPOs may not be considered as attractive of an option compared to two years ago, or even last year. One finance alternative that is re-emerging is debt financing, as […]

24 Feb 2023

Celebrating 20 years of Biotechgate

2023 is a special year for our company: Biotechgate is celebrating its 20th anniversary. Since the launch of its first database in Switzerland in 2003, Biotechgate has continuously evolved into the largest business development and licensing database unique to the life sciences sector. Today, subscribers can explore over 66,000 companies, 760,000 clinical trials, and 27,000 […]

26 Jan 2023

Diagnostics: Industry Trends for 2023

The diagnostics industry has been the subject of increased attention since the emergence of COVID-19, with the market currently estimated at USD 23.2 billion in 2022 and projected to grow 5.4% by 2027 to reach a value of USD 30.2 billion. Here, we discuss three trends that are believed to have an impact on the […]

26 Jan 2023

Building a Strong Relationship with Management

The dynamic between the board of directors and executive leadership is often taken for granted, but plays a key role for the success of a biotechnology company. In a biotech start-up that fuses commercial and scientific functions, it is crucial for the decision-making process in the boardroom to be well-balanced; the executive team – especially […]

22 Nov 2022

The 8 Largest Biopharma M&A Deals of 2022 (Jan-Sep)

Despite 2022 being a relatively quiet year for M&A activity within the biopharma space, especially when compared to 2021, a number of prominent deals have taken place. Find out the 8 largest M&A deals of the year so far in order of the total amount. 8. Zogenix Acquired by: UCB Amount: USD 1.9bn After Zogenix’s […]

19 Oct 2022

Current Trends in M&A Activity

In terms of M&A activity, 2022 is a rather quiet year so far compared to record-breaking year 2021 when private equity investments boomed. In this article, read about recent trends and an outlook on M&A deals in the life science industry. Upswing in biopharma M&As in Q2 2022 According to a report by J.P. Morgan, […]

19 Oct 2022

Strong Partnership with Maryland Department of Commerce: Interview with Ulyana Desiderio

Biotechgate is in close partnership with the Maryland Department of Commerce. In an interview with Ulyana Desiderio, the Director of the Department’s Office of Life Science, she tells Biotechgate about her experience with the partnership and her work in the state’s life science ecosystem. Ulyana Desiderio is Director of the Office of Life Science at […]

22 Sep 2022

The Current State of Therapeutics Financing: Trends in Public Market

Last month’s article on private equity therapeutics financing trends showed how biotech start-ups struggle to raise private equity investment this year, following the pandemic-driven life sciences boom. In this article, we will take a closer look at how recent challenges are reflected in the IPO market and outline public financing trends. In the wake of […]

17 Aug 2022

Finding Financial Information in Biotechgate

With over 1.3 million total entries, the Biotechgate Business Development and Investor databases serve as your primary source of information relating to the life science industry. This allows you to have access to data on organizations from start-ups right through to well-established multinationals and everything in between. Read on for an overview of the financial […]

17 Aug 2022

The 10 Largest Life Science IPOs (January – July, 2022)

IPOs serve as the lifeblood of the life science industry, allowing companies access to a vast source of capital that can fund their R&D activities and give previous investors a return on their initial financing. In 2022, there has been a noted contraction in the performance of life science IPOs which, in turn, has caused […]

17 Aug 2022

The Current State of Therapeutics Financing: Trends in Private Equity Investment

The global pandemic generated record investments in life science companies back in 2020 and 2021, when growth was largely driven by development of COVID-19 vaccines and drugs that helped overcome the acute phase of the pandemic. However, in 2022 the war in Ukraine has led to macroeconomic changes that causes the financial environment for the […]

26 Jul 2022

Oncology Trends: The Story So Far

Oncology has cemented itself as one of the leading therapeutic areas within the biopharma space, with various innovations and changes constantly being introduced in an effort to curb the number of cancer cases and reduce mortality rates. Find some of the key trends that are currently happening within the oncology landscape in this article, including […]

26 Jul 2022

Protecting Your Intellectual Property as a Start-up

Bringing a product to the market is known to be a long journey for life sciences start-ups. It all starts with protecting the underlying ideas and thoughts: the intellectual property (IP). But when is the right time to file a patent application, and at what stage of the process should you think about strategic partnerships […]

23 May 2022

How to Create a Winning Pitch as a Life Science Start-up

Creating an effective pitch that wins over an investor is a difficult task – more so for life science start-ups: Being rarely profitable when they are just starting out, their pitches differ significantly from those of other sectors. What do emerging life science companies need to consider when preparing their pitch decks? How do they […]

20 Apr 2022

The Search for Investors

Are you looking for investors? Finding investors and raising capital is one of the most challenging tasks you will face in business, especially if it’s your first time. It is crucial to be realistic about costs and timelines so you can find the best investor to enhance your company growth. Overall, from start to finish, […]

19 Apr 2022

What to Know Before Fundraising

Raising money is a crucial responsibility for all start-ups active in such a capital-intensive industry like the biopharma space. There are a lot of questions surrounding fundraising, such as where you can receive financing from and what should you to make your company attractive to investors. Read some tips on what to be aware of […]

23 Mar 2022

Find the Latest Information on Life Science Finance Rounds

The Biotechgate financing rounds section contains up-to-date information on fundraising within the life sciences sector. Here, you can find over 23,000 rounds involving companies that have been recently funded, in particular young start-ups as well as organizations post-IPO. In this article, we will show how you can easily find up-to-date rounds according to your needs. […]

23 Mar 2022

Search by Financials and Ownership on Biotechgate

Biotechgate showcases a variety of financial information for companies across all life science sectors, including real-time stock and financial data. This section can be a great help for partnering decisions or give a clearer idea of a company’s current and potential future situation. The company financial section covers a wide range of financial figures and […]

22 Mar 2022

Using Social Media Effectively as a Biopharma Company

Social media should be a fundamental part of every biopharma organization’s marketing strategy. Below are some tips that your company can use to ensure that you are utilizing this marketing channel effectively. Utilize the Right Channels Some organizations feel that they must have a presence across every social media channel in order to garner the […]

23 Feb 2022

How to Promote Your Company at Conferences

Attending conferences is a mandatory requirement when promoting your life science organization, helping to establish credibility as well as increasing awareness about your organization and its operations. Find out how you promote your company effectively when attending these events and conferences. The first step is finding the event. This can be done by asking your […]

23 Feb 2022

The seventh edition of Biotechgate Digital Partnering has come to a close

Zurich, February 2022: From February 7th to 11th, the seventh edition of Biotechgate Digital Partnering took place online on the HelloPartnering conference platform. The conference, focused on BD&L (business development and licensing), saw over 1,200 participants attend, representing over 1,000 companies from 60 countries worldwide. Amongst the one-to-one partnering, workshops and panel discussions, Biotechgate Digital […]

22 Feb 2022

How to Find an International Life Science Partner

The life sciences industry operates in an increasingly globalized sector. Expanding your organization’s scope can enable you to find collaborations that best suit your organization’s needs in terms of R&D or commercialization. Finding a global partner to collaborate with can be easily done through the Biotechgate Business Development database. In the Company Search section, you […]

27 Jan 2022

How to Have a Successful International Partnership

The number of partnerships in life sciences continues to grow as organizations seek to expand their pipeline by collaborating with companies from around the world. With this trend of symbiotic collaboration becoming the industry norm, how can you ensure that your global partnership is successful? Evaluate the Contract Structure Early On When you are negotiating […]

27 Jan 2022

How to Make a Partnering Conference a Success for You

Conferences are an important way for business development professionals in life sciences to find new opportunities, whether it’s collaborating on an asset or seeking investment. Discover below our top three key factors on how to make a partnering conference a success for you. Identify Your Target Audience Firstly, you need to have a clear understanding […]

11 Nov 2021

Using Big Data for Your Life Sciences Business Development

Big data has become a common term across all businesses nowadays, with information and data now serving as a commodity for many organizations. This also applies to the life sciences sector, where big data is used to optimize clinical trial efficacy, improve the targeting of patient populations, and accelerate drug development programs. But it also […]

28 Oct 2021

What Data Does Biotechgate Offer?

With over 1.2 million entries, it may appear overwhelming to correctly utilize the amount of data available on Biotechgate. This article will break down each category that we have available in our business development database to give you a better understanding. Companies Biotechgate contains company information from over 60,000 organizations around the world. While the […]

28 Oct 2021

Should You Use a Database for Business Development?

In the life sciences sector, many organizations choose to invest in third-party databases to aid in their business development activities. For some companies though, the expense may be deemed as unnecessary, choosing to allocate their budget to other areas. Is purchasing a business development database the correct decision for your organization? For people working in […]

28 Oct 2021

How Big Data is used for our Clinical Trials Database

Since its launch in 2019, the Biotechgate clinical trials registry has grown to house over 725,000 studies from around the world. The data is taken from 20 different registries worldwide, ensuring that Biotechgate users are getting the most recent and most accurate data to power their business development. The backbone of the clinical trials database […]

25 Aug 2021

The Current State of Clinical Trials: What are the Latest Trends?

Clinical trials serve as the backbone of pharma and biotech, with the market predicted to reach a value of over USD 77 billion by 2026 according to Research and Markets. They allow for the creation of both new and experimental medicines from well-known ailments like cancers to orphan diseases. Both the industry and the number […]

25 Aug 2021

Denmark Life Science Trend Analysis 2021

In 2020, the Danish life science industry noted the highest number of private equity investments ever, with three of them larger than 40 million US dollars. The number of companies is steadily growing, and there are now almost 600 Danish companies listed in the Biotechgate database. We would like to thank our partner, Copenhagen Capacity, […]

23 Jul 2021

How to Track the Development Phase of a Biotech Asset

How will you know when the development phase of a Biotech, Pharma, or Medtech asset has changed? Biotechgate allows you to easily set up tailored alerts to keep track of when a profile has been updated. The Biotechgate email alerts feature will notify you when there is a change in the phase of a biotech […]

20 Jul 2021

How to Stay Up-to-Date on the Life Science Industry

We know that it can be a tenuous process identifying geographical areas to expand your company’s presence or client base. You may also be looking at other countries to identify new investment prospects. The good news is that we provide many tools to assist you in your screening and decision process. In this article, we […]

18 May 2021

Switzerland Life Science Market Trend Analysis 2021

We are proud to present the annual life science market trend report for Switzerland that was compiled in cooperation with our partners: the Swiss Biotech Association, Basel Area Business & Innovation, Life Science Zurich, Canton of Zurich, and the City of Zurich. The report shows the thriving nature of the Swiss biotech industry that proved […]

26 Apr 2021

United Kingdom Life Science Trend Analysis 2021

2020 was a great year for the British biotech industry. The total value of private equity investments was twice as high compared to 2019 and exceeded the 2018 level that had been the highest since we begun tracking data. The UK remains the largest life science market in Europe when it comes to the number […]

29 Mar 2021

New Search Functions are Now Available in Biotechgate

At Biotechgate, we are always open to customer feedback and ensuring that you have the best experience possible when browsing our database. Thanks to your comments, we have now implemented a number of new features for searching and filtering our 1.2 million entries in order to give you the best result. Redefined Search for Preclinical […]

22 Mar 2021

Enjoy an Enhanced User Experience With Our New Website Release

Biotechgate has grown a lot over the course of the year. In total, the Biotechgate database has over 1.1 million active entries and several millions of records including historical data. Managing this volume of information is challenging, both from a technical point of view as well as being able to find the information you want […]

22 Mar 2021

How to Find Diagnostic Assets in Biotechgate

Assets listed in Biotechgate are grouped into four sections: therapeutics, molecular diagnostics, medical devices and technologies. The divide is rather logical, but for some users, especially those familiar with the classification of products for regulatory purposes, it may not be clear how we distinguish molecular diagnostics from diagnostic medical devices. In this article, we discuss […]

22 Mar 2021

Dutch Life Sciences Trend Analysis 2021 – Biotech Companies Show To Be Resilient And See Venture Financing Grow In 2020

Wednesday, 3 March 2021 Biotechgate, the leading global biotech database, presents their annual Trend Analysis Report 2021 of the Dutch life sciences sector. The report shows the resilience of the Dutch biotech sector. Although the coronavirus had a negative impact on the amount of clinical trials, biotech companies attracted double the amount of venture […]

03 Mar 2021

Korean Life Science Market Trend Analysis 2021

We are presenting the Korean Life Science Market Trend Analysis 2021 prepared in cooperation with our partner Seoul BioHub operated by KHIDI (Korea Health Industry Development Institute).

24 Feb 2021

Enterprise Lithuania becomes a partner of Venture Valuation/Biotechgate

Media release Enterprise Lithuania becomes a partner of Venture Valuation/Biotechgate Zurich / Vilnius, Jan 2021 Venture Valuation/Biotechgate announce a cooperation with Enterprise Lithuania, trade promotion governmental agency. As per the agreement of the two parties, the Lithuanian Biotech Database has been set-up, a regional portal integrated with Biotechgate Business Development Database. Access to the portal […]

27 Jan 2021

Winning start-ups as customers – timing is crucial

Working with start-ups can be both highly promising and risky. On the one hand, there is no greater potential for the future as with an emerging company. On the other hand, new entrepreneurs often lack the funds to be able to make a long-term commitment with partners and suppliers. That is why the right timing […]

03 Jan 2021

Trends and facts on licensing deals

Biotechgate Digital Partnering, virtual, November 2020, 23 pages Presentation

25 Nov 2020

Life science asset database

We regularly hear about new licensing agreements between pharmaceutical and biotech companies. These usually involve assets – such as therapeutics, diagnostics, medical devices or technologies – which are to be developed or marketed together. A big challenge however is to find the right partner for the right asset. The Biotechgate database features almost 90,000 life […]

21 Oct 2020

Launch of the Life Science Directory for Medicen Paris

Media Release Launch of the Life Science Directory for Medicen Paris Zurich / Paris, Oct 2020 – Venture Valuation owned Biotechgate announces the partnership with Medicen Paris Region to create a directory of Life Sciences companies. The online directory makes it easier to find partners in one of the key clusters in Europe. Venture Valuation/Biotechgate […]

30 Sep 2020

Canadian Life Science Market Trend Analysis 2020

Together with our partners – Montreal Invivo, BioAlberta and BIOTECanada – we are happy to present an extended annual report on the Canadian life science market. Besides the usual statistics about companies, products and investments, the new format of the report includes data on clinical trials acquired from the new section of Biotechgate database.

28 Jul 2020

Denmark Life Science Market Trend Analysis 2020

The number of biotech companies in Denmark relative to the population is one of the highest in the world with Copenhagen being a very important European cluster. Last year Danish biotech was boosted with several large financing rounds with the volume as high as dozens of millions of dollars each. See the details in the […]

27 May 2020

Swiss Life Science Market Trend Analysis 2020

Our annual Swiss market trend analysis compiled with Biotechgate data shows that the life science industry in Switzerland is thriving. The amount of money raised in venture financing rounds in 2019 was nearly twice as large as in 2018. Also, more new biotech companies were launched last year than two years ago.

30 Mar 2020

The Launch of the Rhine-Main-Neckar Directory

Zurich 03 March 2020 Last month Biotechgate/Venture Valuation entered a partnership with BioRN, the science and industry cluster of the Rhine-Main-Neckar region, with the goal to develop and run a publicly accessible directory of companies located in the region. The Directory has recently been launched and is accessible for free on BioRN’s website. While it […]

05 Mar 2020

How we use Big Data for curation of the Clinical Trial Database

The clinical trials database that we launched in March this year, has already grown from the initial 460,000+ records to over 500,000. It has been possible thanks to the integration with more than 13 registries around the world – a result of a Big Data project called DISCOVER in collaboration with the Swiss Institute for […]

23 Jul 2019

Partnering and match-making system with data from Biotechgate

Partnering conferences are an essential part of the business development activities in the life science industry. Our premium match-making system HelloPartnering lets conference participants plan and schedule their meetings in advance. What sets HelloPartnering apart is that data about assets and companies is populated from Biotechgate, meaning: No more “empty” company profiles in a conference […]

10 Jul 2019

Site Selection Report for Life Sciences Companies in Europe 2018

The new Site Selection Report for Life Sciences Companies in Europe, compiled by KPMG in association with Venture Valuation, explores the when, where and how of successful European expansion. The publication looks beyond site selection to include key work streams involved in successfully commercializing pharmaceutical products in Europe. In the 2018 edition, we identify five […]

20 Dec 2018

Launch of a Directory of Life Sciences and Health Technologies companies with an exclusive database in Québec

Zurich / Montréal, November 26, 2018 As part of the ongoing commitment of Montréal InVivo to promote the economic development and growth of the life sciences and health technologies (LSHT) sector in Québec, Biotechgate, a company owned by Venture Valuation, and Montréal InVivo, the LSHT industrial cluster of the Montreal metropolitan area, announce a partnership […]

26 Nov 2018

The Antibiotics Resistance Challenge: Find Out-Licensing Opportunities and More on Biotechgate

Antibiotic resistance has become a significant problem in the global healthcare market. Over-prescribing and misuse, along with the lack of new drug development, means that both governments and the life science industry as a whole have begun to take steps to partner with or fund those companies researching infectious diseases; this is especially true for […]

19 May 2016

Site Selection for Life Sciences Companies in Europe

2015 edition The “Site Selection for Life Sciences companies in Europe” report analyzes the structure of the European life sciences landscape and looks at the strength of the Biotech, Medtech and Pharma industry of the specific market. The 2015 edition of the report includes a comparison of the following countries: Austria, Belgium, Denmark, France, Finland, […]

17 Nov 2015

How strong is the London-Cambridge cluster within the UK?

Our exclusive analysis we did for the Genesis conference (organized by our partner Onenucleus). Download the report >> Looking for your next Biotech or Medtech partner? Use Biotechgate to identify new leads, licensing opportunities and management details. Get started now Learn more

17 Dec 2014

Biotechgate starts collaboration with HTX to produce Canadian Medtech Database

Venture Valuation, the owner of Biotechgate, announces that a consortium led by The Health Technology Exchange (HTX), partnered with Biotechgate in launching a Canadian medical technology industry specific database. Click here to read the press release >>

08 Sep 2014

Focus on China: Medical Device Market

China`s medical device market is the fourth-largest in the world, estimated to be USD 11bn in 20091. However, medical device per capita expenditure is still very low and the Chinese medical device market is one of the fastest growing markets in the world. In the course of this year, Venture Valuation will endeavor to provide […]

14 Jun 2013

Biotechgate Partner BIOCAT launches new directory

The new Biocat Directory is now available after signing an agreement with Venture Valuation – the owner of the benchmark international database BiotechGate – Venture Valuation will bring together the information from both bodies in an easy to use single search engine. The new version of the directory is a qualitative improvement on the public […]

17 Jan 2013

Biotechgate reaches 25’000 company profiles

Biotechgate company and deals database, run by Venture Valuation, has reached a record 25`000 companies. The data is up-dated on an ongoing basis by Venture Valuations own team, with the assistance of the listed companies themselves (over 40%), and through our 30 plus Biotech association partners and economic development agencies. These partners use Biotechgate as […]

01 Nov 2012

Life sciences Ontario, new long-term partner for Biotechgate

The new partner joins a group of over 30 partners worldwide, mainly Biotech Associations and Economic Development agencies. Biotechgate`s global partners include organisations in Canada (BIOTECanada), US, Switzerland, Netherlands, Germany, South Korea, Denmark, Sweden and the new member states in the European Union. With over 24’000 company profiles from around the world, Biotechgate (www.biotechgate.com ) […]

09 Oct 2012

Interviews with leading Life Sciences companies: Interprotein Corporation

Interviews with leading Life Sciences companies: Interprotein Corporation English (PDF) – 3 pages – 680kb

09 Mar 2012

Interviews with leading Life Sciences companies: AVA-CO2 Schweiz AG

Interviews with leading Life Sciences companies: AVA-CO2 Schweiz AG English (PDF) – 4 pages – 1001kb

20 Feb 2012

Interviews with leading Life Sciences companies: Next Energy & Resouces Co. Ldt.

Interviews with leading Life Sciences companies: Next Energy & Resouces Co. Ldt. English (PDF) – 3 pages – 791kb

22 Sep 2011

Interviews with leading Life Sciences companies: Mebiol Inc

Interviews with leading Life Sciences companies: Mebiol Inc English (PDF) – 4 pages – 331kb

24 Apr 2011

Interviews with leading Life Sciences companies: Sawai

Interviews with leading Life Sciences companies: Sawai English (PDF) – 4 pages – 182kb

24 Jul 2010

Interviews with leading Life Sciences companies: Sensimed

Interviews with leading Life Sciences companies: Sensimed English (PDF) – 4 pages – 398kb

24 May 2010

Interviews with leading Life Sciences companies: GenKyoTex

Interviews with leading Life Sciences companies: GenKyoTex English (PDF) – 4 pages – 268kb

24 Feb 2010

Interviews with leading Life Sciences companies: Linical

Interviews with leading Life Sciences companies: Linical English (PDF) – 3 pages – 163kb

24 Jan 2010

Interviews with leading Life Sciences companies: POC Clinical Research

Interviews with leading Life Sciences companies: POC Clinical Research English (PDF) – 3 pages – 218kb

24 Jan 2010

Interviews with leading Life Sciences companies: Interprotein

Interviews with leading Life Sciences companies: Interprotein English (PDF) – 4 pages – 217kb

24 Nov 2009

Interviews with leading Life Sciences companies: ArBlast Co.

Interviews with leading Life Sciences companies: ArBlast Co. English (PDF) – 3 pages – 182kb

24 Oct 2009

Interviews with leading Life Sciences companies: Watervein Partners

Interviews with leading Life Sciences companies: Watervein Partners English (PDF) – 3 pages – 209kb

24 Oct 2009

Interviews with leading Life Sciences companies: Nanoegg

Interviews with leading Life Sciences companies: Nanoegg English (PDF) – 4 pages – 279kb

24 Aug 2009

Interviews with leading Life Sciences companies: Anaeropharma Science

Interviews with leading Life Sciences companies: Anaeropharma Science English (PDF) – 3 pages – 256kb

24 Jul 2009

Interviews with leading Life Sciences companies: Kringle Pharma

Interviews with leading Life Sciences companies: Kringle Pharma English (PDF) – 3 pages – 251kb

24 Jul 2009

Interviews with leading Life Sciences companies: JCAM

Interviews with leading Life Sciences companies: JCAM English (PDF) – 3 pages – 184kb

24 May 2009

Interviews with leading Life Sciences companies: NanoCarrier

Interviews with leading Life Sciences companies: NanoCarrier English (PDF) – 3 pages – 226kb

24 May 2009

Interviews with leading Life Sciences companies: Carna Bioscience

Interviews with leading Life Sciences companies: Carna Bioscience English (PDF) – 2 pages – 262kb

24 Apr 2009

Interviews with leading Life Sciences companies: MediciNova, Inc.

Interviews with leading Life Sciences companies: MediciNova, Inc. English (PDF) – 2 pages – 187kb

24 Apr 2009

Interviews with leading Life Sciences companies: SBI Biotech Co., Ltd. (SBIBT)

Interviews with leading Life Sciences companies: SBI Biotech Co., Ltd. (SBIBT) English (PDF) – 2 pages – 212kb

24 Mar 2009

Interviews with leading Life Sciences companies: Institute of Medicinal Molecular Design, Inc. (IMMD)

Interviews with leading Life Sciences companies: Institute of Medicinal Molecular Design, Inc. (IMMD) English (PDF) – 2 pages – 153kb

24 Mar 2009

Interviews with leading Life Sciences companies: Japan Tissue Engineering Co., Ltd. (J-TEC)

Interviews with leading Life Sciences companies: Japan Tissue Engineering Co., Ltd. (J-TEC) English (PDF) – 2 pages – 239kb

24 Mar 2009